Journal of Surgical Research
Volume 153, Issue 1 , Pages 39-45 , 1 May 2009

Protective Effects of a Heme Oxygenase-1-Secreting Lactococcus lactis on Mucosal Injury Induced by Hemorrhagic Shock in Rats

  • Qing-feng Pang, Ph.D.

      Affiliations

    • Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province, People's Republic of China
    • ,
  • Yong Ji, Ph.D.

      Affiliations

    • Jiangsu Province Institute of Anesthesiology, Xuzhou Medical College, Xuzhou, Jiangsu Province, People's Republic of China
    • ,
  • Luis G. Bermúdez-Humarán, Ph.D.

      Affiliations

    • INRA, Jouy-en-Josas, France
    • ,
  • Qiao-mei Zhou, M.D.

      Affiliations

    • Jiangsu Province Institute of Anesthesiology, Xuzhou Medical College, Xuzhou, Jiangsu Province, People's Republic of China
    • ,
  • Gang Hu, Ph.D.

      Affiliations

    • Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province, People's Republic of China
    • ,
  • Yinming Zeng, Ph.D.

      Affiliations

    • Jiangsu Province Institute of Anesthesiology, Xuzhou Medical College, Xuzhou, Jiangsu Province, People's Republic of China
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Jiangsu Province institute of Anesthesiology, Xuzhou Medical College, Xuzhou, Jiangsu Province, People's Republic of China, 221002

Received 20 December 2007

References 

  1. Hassoun HT, Kone BC, Mercer DW, et al. Post-injury multiple organ failure: The role of the gut. Shock. 2001;15:1
  2. Ozono R. New biotechnological methods to reduce oxidative stress in the cardiovascular system: Focusing on the Bach1/heme oxygenase-1 pathway. Curr Pharm Biotechnol. 2006;7:87
  3. Wang HH, Zhou HY, Chen CC, et al. Propofol attenuation of renal ischemia/reperfusion injury involves heme oxygenase-1. Acta Pharmacol Sin. 2007;28:1175
  4. Jin HF, Du JB, Li XH, et al. Interaction between hydrogen sulfide/cystathionine g-lyase and carbon monoxide/heme oxygenase pathways in aortic smooth muscle cells. Acta Pharmacol Sin. 2006;27:1561
  5. Rayner BS, Duong TT, Myers SJ, et al. Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury. J Neurochem. 2006;97:211
  6. Yet SF, Perrella MA, Layne MD, et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest. 1999;103:R23
  7. Otterbein LE, Kolls JK, Mantell LL, et al. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest. 1999;103:1047
  8. Hashiba T, Suzuki M, Nagashima Y, et al. Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther. 2001;8:1499
  9. Tulis DA, Durante W, Liu X, et al. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 2001;104:2710
  10. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4:346
  11. Vandenbroucke K, Hans W, Van Huysse J, et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology. 2004;127:502
  12. Steidler L. In situ delivery of cytokines by genetically engineered Lactococcus lactis. Antonie Van Leeuwenhoek. 2002;82:323
  13. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000;289:1352
  14. Zhang J, Liu JZ, Tan SZ, et al. The progressive study on gene therapy for hyperphenylalaninemia rats. Sheng Wu Gong Cheng Xue Bao. 2002;18:713
  15. Langella P, Le Loir Y. Heterologous protein secretion in Lactococcus lactis: A novel antigen delivery system. Braz J Med Biol Res. 1999;32:191
  16. Raha AR, Varma NR, Yusoff K, et al. Cell surface display system for Lactococcus lactis: A novel development for oral vaccine. Appl Microbiol Biotechnol. 2005;68:75
  17. Sridhar VR, Smeianov VV, Steele JL. Construction and evaluation of food-grade vectors for Lactococcus lactis using aspartate aminotransferase and alpha-galactosidase as selectable markers. J Appl Microbiol. 2006;101:161
  18. Bermúdez-Humarán LG, Cortes-Perez NG, Ah-Leung S, et al. Current prophylactic and therapeutic uses of a recombinant Lactococcus lactis strain secreting biologically active interleukin-12. J Mol Microbiol Biotechnol. 2008;14:80
  19. Jeong DW, Lee JH, Kim KH, et al. A food-grade expression/secretion vector for Lactococcus lactis that uses an alpha-galactosidase gene as a selection marker. Food Microbiol. 2006;23:468
  20. Wu C, Zeng Y, Pang Q. Cloning and expression of rat heme oxygenase-1 gene in Lactococcus lactis. Chin J Appl Environ Biol. 2006;12:48
  21. Ryter SW, Kvam E, Tyrrel RM. Heme oxygenase activity: Current methods and applications. Methods Mol Biol. 2000;99:369
  22. Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low flow states. Arch Surg. 1970;101:478
  23. Dantzker DR. The gastrointestinal tract, the canary of the body. JAMA. 1993;270:1247
  24. Kirkby KA, Adin CA. Products of heme oxygenase and their potential therapeutic applications. Am J Physiol Renal Physiol. 2006;290:F563
  25. Hill-Kapturczak N, Chang SH, Agarwal A. Heme oxygenase and the kidney. DNA Cell Biol. 2002;21:307
  26. Nath KA, Haggard JJ, Croatt AJ, et al. The indispensability of heme oxygenase-1 in protecting against acute heme protein- induced toxicity in vivo. Am J Pathol. 2000;156:1527
  27. Bach FH. Heme oxygenase-1: A therapeutic amplification funnel. FASEB J. 2005;19:1216
  28. Choi AM, Dolinay T. “Therapeutic” carbon monoxide may be a reality soon. Am J Respir Crit Care Med. 2005;171:1318
  29. Eyssen-Hernandez R, Ladoux A, Frelin C. Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia. FEBS Lett. 1996;382:229
  30. Morse D, Choi AM. Heme oxygenase-1: The “emerging molecule” has arrived. Am J Respir Cell Mol Biol. 2002;27:8
  31. Uehara K, Takahashi T, Fujii H, et al. The lower intestinal tract-specific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury. Crit Care Med. 2005;33:381
  32. Exner M, Minar E, Wagner O, et al. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radical Biol Med. 2004;37:1097
  33. Ono K, Goto Y, Takagi S, et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis. 2004;173:15
  34. Abraham NG, Asija A, Drummond G, et al. Heme oxygenase-1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther. 2007;7:89
  35. Tamion F, Richard V, Bonmarchand G, et al. HO-1 induction prevents inflammatory response after hemorrhagic shock. Am J Respir Crit Care Med. 2001;164:1933
  36. Yamaguchi T, Tearkado M, Horio F, et al. Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of hemeoxygenase. Biochem Biophys Res Commun. 1996;223:129
  37. Pannen BHJ, Kohler N, Hole B, et al. Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats. J Clin Invest. 1998;102:1220

PII: S0022-4804(08)00263-1

doi: 10.1016/j.jss.2008.03.042

Journal of Surgical Research
Volume 153, Issue 1 , Pages 39-45 , 1 May 2009

Article Tools

* Image Usage & Resolution